NIKKEI FT Communicable Diseases Conference

Dr. Keishi ABE

Senior Fellow, GRIPS ALLIANCE, National Graduate Institute for Policy Studies

Hideaki ANAN, MD, PhD, FJSIM

Chief Executive of Medical Crisis Measures, Kanagawa Prefectural Government/ Deputy Director, Fujisawa City Hospital

Dr. ARAKI Hiroto, MD, PhD

Director

Research and Development Policy Division, Health Policy Bureau

Ministry of Health, Labour and Welfare

Dr. Yasuhiro ARAKI, PhD

Director, Office of Vaccines and Blood Products, Pharmaceuticals and Medical Devices Agency

Dr. Kazunari ASANUMA, MD, PhD

Senior Assistant Minister for Health Security and Technology,

Minister's Secretariat,

kouMinistry of Health, Labour and Welfare

Mr. Stéphane BANCEL

Chief Executive Officer, Moderna Inc.

Dr Seth BERKLEY

Chief Executive Officer,

Gavi, the Vaccine Alliance

Michael CHEN, MD

Associate Professor of Perioperative Medicine

Director of Pediatric Neuroanesthesia

Co-chair of Pharmacy & Therapeutics, LPCH

Stanford University

Professor Rita R. COLWELL

Distinguished University Professor, University of Maryland Institute of Advanced Computer Studies (UMIACS), University of Maryland College Park, USA

Mr. Thomas B. CUENI

Director General

International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)

Mr. Safwan DAMES

Africa Business Development Team, Saraya Co., Ltd.

Professor Dame Sally DAVIES

UK Government Special Envoy on Antimicrobial Resistance

UK Department of Health and Social Care

Dr. Satoshi EZOE, MD,MPH,MPA,PhD

Director,

Global Health Strategy Division, International Cooperation Bureau Ministry of Foreign Affairs

Damiano DE FELICE, Ph.D.

Director of Development and External Engagement, CARB-X

Greg FRANK, PhD

Director, Global Public Policy, MSD

Prof Jeff FRENCH

Visiting Professor Brighton University Business School UK and CEO of Strategic Social Marketing

Yoko FUJIMOTO, M.D., Ph.D.,

Pfizer Japan Inc.

Japan Vaccines BU Lead / Japan Hospital BU Lead

Toshiharu FURUKAWA, M.D.,M.B.A.,Ph.D.

Member of The House of Councillors/Professor of Healthcare Law and Surgery, Law School and Medical School, Keio University/Attorney-at-law, TMI Associates

Mr. Milano FURUTA

President, Japan Pharma Business Unit

Takeda Pharmaceutical Company Limited

M.D.,Ph.D Michinari HAMAGUCHI

Director General, Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response(SCARDA), Japan Agency for Medical Research and Development (AMED)

Dr. Akihisa HARADA, M.D., Ph.D.

President & Representative Director

Pfizer Japan Inc.

Mr. Ryousuke HARADA

Senior Exective Editor

Nikkei Inc.

PhD Tomoyuki HASHIMOTO

Director,

Japan Environmental Sanitation Center

Dr Richard HATCHETT

CEO CEPI

Eiji HINOSHITA, MD, PhD, MSc

Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare of Japan

Prof. Kenji HIRAYAMA, MD. Ph.D.

Professor / School of Tropical Medicine and Global Health, Nagasaki University

Mr. Yoshihide HIRUTA

Director of International Cooperation, International Business Management, Global Management

Sysmex Corporation

Mr. Takeo HOJO

General Manager,

Africa Business Development Sect., Global Operation Div., SARAYA CO., LTD.

Mr. Shigeki HONDA, MBA

Advisor, Minerva Veritas Co.,Ltd. /

Specially Appointed Professor, Shinshu University

Tatsuo IIYAMA, M.D.

Director, Department of International Trials, Center for Clinical Sciences,

National Center for Global Health and Medicine (NCGM)

Mr. Masayuki IMAGAWA, M.B.A., M.Sc., R.Ph.

Head, Vaccine Business Unit, Takeda Pharmaceutical Co., Ltd

Chief Executive, Japan Association of Vaccine Industries

Dr. Akifumi IMAMURA, M.D.

Director

Department of Infectious Diseases

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Mr. Masakatsu IMOTO

Healthcare Policy Director

National Healthcare Policy Secretariat, Cabinet Office, Government of Japan

Hajime INOUE, MD, MPH, DrPH

The World Bank

Advisor; Health, Nutrition, and Population

Ken J. ISHII, M.D., Ph.D.

Professor,

Division of Vaccine Science, Department of Microbiology and Immunology

The Institute of Medical Science, The University of Tokyo

Mr. Kota IWAHASHI

Administrative Director, NPO akta

Mr. Masanobu IWASA

NIPRO CORPORATION

Director PharmaPackaging Division

Dr Zsuzsanna JAKAB

Deputy Director-General of WHO

Prof. Yasuhiko KAMIYA, MD, MtroPaed, PhD

School of Tropical Medicine and Global Health,

Nagasaki University

Prof. Akira KANEKO, MD, PhD, DTM&H

Osaka Metropolitan University

Karolinska Institutet

Mr. Kenichi KANEKO

CEO

ICheck Co., Ltd.

Prof. Dr. KANO Mitsunobu, MD/PhD

Vice Executive Director, Dean of School of Pharmaceutical Sciences and Professor

Okayama University

Council Member, Science Council of Japan

Dr. Shigeyuki KANO, MD, PhD, Hon PhD (Mahidol)

Director,

Department of Tropical Medicine and Malaria,Research Institute,

National Center for Global Health and Medicine (NCGM)

Prof. Quarraisha Abdool KARIM

Associate Scientific Director, Centre for the AIDS Programme of Research in South Africa (CAPRISA)

Dr. Salim S. Abdool KARIM

Director, Centre for the AIDS Programme of Research in South Africa (CAPRISA)

Dr. Richard H. KASZYNSKI

Director and Chief Medical Officer, ICheck Co., Ltd

Co-founder and Director, Stanford Solutions, Stanford Medical School

Dr. Seiya KATO

Director,

Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/ JATA)

Prof. Yoshihiro KAWAOKA DVM, PhD

Director Research Center for Global Viral Diseases National Center for Global Health and Medicine Research Institute

Project Professor, The Institute of Medical Science, The University of Tokyo

Dr. Toshihide KIDOKORO, MD

Director, Tokyo Metropolitan Testing and Counseling Office (Shinjuku-Higashiguchi)

Prof. KITA Kiyoshi

Dean and Professor,

School of Tropical Medicine and Global Health,

Nagasaki University

The University of Tokyo, Professor Emeritus

Dr. Kanako KITAHARA , MD, PhD

Office for COVID-19 and Other Emerging Infectious Disease Control / Counsellor : Cabinet Secretariat, Government of Japan

Junichi KOGA，Ph.D.

Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) / Provost : Japan Agency for Medical Research and Development（AMED）

Mr. Shinichi KOHGUCHI

Senior Stewardship Officer Stewardship Development Department,

Sumitomo Mitsui Trust Asset Management Co.,Ltd.

Ms Yui KOHNO

Health and Global Policy Institute (HGPI) Manager

Mr. Michikazu KOSHIBA

MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.

Head, Center on Global Health Architecture/General Manager, Social Impact Partnership Business Dept.

Mr. Mamoru KUBOTA

Senior Executive Officer,

Business Development,

Sysmex Corporation

Prof. Osamu KUNII, MD, MPH, PhD,

CEO and Executive Director at the GHIT Fund

Dr. Kiyoshi KUROKAWA

Chair, Hideyo Noguchi Africa Prize Committee

Chair of the Board, Health and Global Policy Institute

Professor Emeritus, the University of Tokyo, National Graduate Institute for Policy Studies and Tokai University

Mr. Tatsuro KUZUKI

R&D Liaison

NPO DNDi Japan

Dr. Hideo MAEDA,MD, MPH

Director,

Tokyo Kita City Public Health Center

Mr.Kuniyuki MAKIE

Executive Officer

Media & Business Solutions

Nikkei Inc.

Prof. Dr. Izuru MAKIHARA

Professor

Research Center for Advanced Science and Technology, University of Tokyo

Dr. Sunao MANABE, DVM, PhD

Representative Director, President and CEO

Daiichi Sankyo Co., Ltd.

Ms. Kyoko MATSUMOTO

Senior Associate : Remiges Ventures, KK

Prof. Shuzo MATSUSHITA MD, PhD

Director; Joint Research Center for Human Retrovirus Infection, Division of Clinical Retrovirology, Kumamoto and Kagoshima Universities

Prof. Noboru MINAKAWA Ph.D.

Institute of Tropical Medicine, Nagasaki University

Professor,

Ms.Yori MISHIMA

Sales department, ICheck Co., Ltd

Mr. Takeshi MITANI

Chairman Japan CMO Association

Kuniaki MIYAKE MD,MSc

CMO,CHO

DeNA

Mr. Mitsuru MIYATA

CEO

Miyata Institute of Technologies,K.K.

Mr. Eamonn MURPHY

Deputy Executive Director, Joint United Nations Programme on HIV/AIDS（UNAIDS）

Mr. Toshiaki NAGASATO

President and Representative Director

KM Biologics Co.,Ltd

Mr. Sumiya NAGATSUKA

Staff Manager, Healthcare Business Headquarters, Konicaminolta, Inc.

Chairman of Radiation & Dose Committee, Japan Medical Imaging and Radiological Systems Industries Association（JIRA）

Chairman of Technological PR Expert Committee, Japan Medical Imaging and Radiological Systems Industries Association（JIRA）

Dr.Yoshinari NAKAHARA

Assistant Manager,

Fumakilla Ltd.

Prof. Dr. Kazutoshi NAKASHIMA, MD, PhD

Professor

Department of Health Science, Faculty of Sports and Health Science,

Daito Bunka University

Prof. Yumiko NARA, PhD

Professor,

Graduate School of Human Life and Health Sciences Program,

The Open University of Japan

Mr. Takeshi NARUSE

Managing Executive Officer R&D Division / Senior Manager / KM Biologics Co., Ltd.

Mr.Takatsugu NIKI

Director, ZENSEDAI

Co-Chair, Youth Democracy Promotion Agency

Dr. Itaru NISHIZUKA

Former Director General, Sumida City Public Health Center.

Director General, Tokyo Metropolitan Government

Mr. Ryoji NORITAKE

CEO and Board Member,

Health and Global Policy Institute (HGPI)

Prof. Kazumasa OGURO

Professor

Hosei University

Norio OHMAGARI, M.D., M.Sc., Ph.D.

Director

National Center for Global Health and Medicine Hospital

Disease Control and Prevention Center

Dr. Shinichi OKA, MD, PhD

Director of AIDS Clinical Center,

National Center for Global Health and Medicine

Dr. Kunio OKADA

President Non-Profit Organization Kenkokeiei

Mr. Yasushi OKADA

Chairman Japan Pharmaceutical Manufacturers Association

Dr. Shigeru OMI, MD, PhD

Japan Anti-Tuberculosis Association, Chairman, Representative,Board of Director

World Health Organization (WHO), Regional Office for Western Pacific

Dr.Wycliff OMONDI

Head Division of Vector Borne & Neglected Tropical Diseases

Ministry of Health – Republic of Kenya

Masayuki OMOTE, PhD

Executive Director, Clinical Development Japan, Gilead Sciences KK

Prof. Kevin OUTTERSON

Professor of Law & N. Neal Pike Scholar in Health and Disability Law - Boston University Executive Director, CARB-X

Mr. Michael PEEL

Executive editor

Nikkei Asia

Mrs Heulwen PHILPOT

Head of International Pandemic Preparedness Secretariat

Ms. Dagmar REITENBACH

Head of the Global Health Team in the German Ministry of Health

Dr, Haruka SAKAMOTO, MD, PhD

Associate Professor

Tokyo Women’s Medical University, Section of Global Health

Mr. Peter SANDS

Executive Director

The Global Fund to Fight AIDS, Tuberculosis and Malaria

PhD. Tomonori SASAKI

FUMAKILLA LIMITED / RESEARCH & DEVELOPMENT DIVISION / FUNDAMENTAL SCIENCE RESEARCH DEPARTMENT / ASSISTANT SENIOR MANAGER

Ms. Takuko SAWADA

Director and Vice Chairperson of the Board, Shionogi & Co., Ltd.

Dr. Koshin SEKIMIZU, PhD

President and CEO, Provigate, Inc.

Mayumi SHIKANO, ph.D.

Professor, Faculty of Pharmaceutical Sciences

Tokyo University of Science

Prof. Nahoko SHINDO, MD, PhD

Senior Advisor,

WHO Health Emergencies Programme (WHE),

World Health Organization

Ms. Hitomi SHIMATANI

CEO

Eye-Land.Co.,ltd.

Outside Director / Ambassador

ICheck Co.,Ltd.

Mr. Hirokazu SHIMODA

Director, Bio-Industry Division,

Ministry of Economy, Trade and Industry(METI)

Kengo SONODA, PhD

Development Department / General Manager KM Biologics Co.,Ltd

Prof. Dr. Tomohiko SUGISHITA

Section of Global Health, Department of Public Health, Tokyo Women’s Medical University

Dr. Yosuke SUNAHARA

Kobe University

Graduate School of Law

Dr. Motoi SUZUKI, MD PhD

Director

Center for Surveillance, Immunization,

and Epidemiologic Research

National Institute of Infectious Diseases

Rami SUZUKI Ph.D.

President & Representative Director, Moderna Japan Co., Ltd.

Prof. Yasuhiro SUZUKI

President

International University of Health & Welfare

TACHIYA Hidekiyo,MD

Mayor of Soma City

Prof. Dr. Ayato TAKADA, DVM, PhD

Hokkaido University

International Institute for Zoonosis Control, Division of Global Epidemiology

Mr. Takashi TAKAMI

Assistant Manager,

Biochemical Laboratory, Saraya Co., Ltd.

Dr. Yoshihiro TAKAYAMA, MD

Deputy director

Division of Infectious Diseases

Okinawa Chubu Hospital

Prof. Keizo TAKEMI

Member, the House of Councillors

Co-Chair of the UNDP’s High-Level Advisory Panel for the Special Report on Human Security

Chairperson of the Special Committee on Global Health Strategy of the LDP

Acting Chairperson of Headquarters for Novel Coronavirus Measures of the LDP

Senior Fellow with the Japan Center for International Exchange (JCIE)

Chair of the Executive Committee on Global Health and Human Security

Visiting Professor at Nagasaki University

Mr. Atsunobu TAKESHITA

President and Chief Executive Officer Publisher

NIKKEI SCIENCE, INC.

Norio TAMURA, MBA, Ph.D

SHIONOGI & CO., LTD.

Vice President Vaccine and Diagnostic Drug Department

Mr. TANAKA KAZUSHIGE

Deputy Director-General, Ministry of Economy, Trade and Industry,

Dr. Junko TANUMA, MD, PhD

Chief, Division of AIDS Medical Information

AIDS Clinical Center, Center Hospital of the National Center for Global Health and Medicine

Dr. Kazuhiro TATEDA, MD, PhD

Professor

Department of Microbiology and Infectious Diseases /

Toho University School of Medicine

Yasunori TAWARAGI, PhD

Environmental Management and Global Health Group Sustainability Promotion Department

DAIICHI SANKYO CO.,LTD.

Mr. Toru TANZAWA

Vice President

Vaccine Business Department Japane Business Unit Daiichi Sankyo Co., Ltd.

Isao TESHIROGI, Ph.D.

Chief Executive Officer

Shionogi & Co., Ltd.

Dr. Amit N THAKKER

Executive Chairman Africa Health Business

Mr. Susumu TSUBAKI

Representative Director / CEO

Asia Africa Investment and Consulting Pte. Ltd.(AAIC)

Prof. Yoko URYUHARA, MBA, PhD

Professor,

Faculty of Commerce, Doshisha University Director, Social Marketing Research Centre

Prof. Koji WADA, MD, MSc, PhD

Senior Director, Vaccine Medical Affairs Japan Lead, Pfizer Japan Inc.

Ms. Keiko WATANABE

Section-Ⅰ,Marketing Department-Ⅲ Marketing Office, EIKEN CHEMICAL Co.,LTD.

Adam Joseph WEISS, M.P.H.

Director, Guinea Worm Eradication Program, The Carter Center